CLDI — CALIDI BIOTHERAPEUTICS INC
As of Q2 2026, 5 SEC-registered investment managers reported holding CLDI (CALIDI BIOTHERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $26.86K across 158.03K shares. That is +72.6% by share count (+66.47K shares) versus the previous quarter, while reported value moved +22.9%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions, 3 added to existing stakes, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
CLDI is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| D. E. Shaw & Co history | Q2 2022 | 820.02K | $8.15M | 0.01% | Hold |
| Deutsche Bank AG history | Q2 2023 | 139.49K | $1.46M | 0.00% | Hold |
| Millennium Management history | Q4 2024 | 136.14K | $156.56K | 0.00% | New |
| Vanguard Group history | Q4 2025 | 34.73K | $40.63K | 0.00% | Hold |
| Geode Capital Management history | Q2 2026 | 114.55K | $19.47K | 0.00% | Add |
| Citadel Advisors history | Q2 2025 | 71.20K | $16.38K | 0.00% | New |
| Marshall Wace history | Q2 2024 | 61.87K | $12.37K | 0.00% | Hold |
| Goldman Sachs Group history | Q2 2025 | 13.21K | $3.04K | 0.00% | New |
| Northern Trust Corp history | Q2 2026 | 17.76K | $3.02K | 0.00% | Hold |
| Morgan Stanley history | Q2 2026 | 13.24K | $2.25K | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 7.88K | $1.34K | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 4.59K | $781 | 0.00% | Add |
| JPMorgan Chase & Co history | Q1 2026 | 1.04K | $248 | 0.00% | New |
| Wells Fargo & Co history | Q1 2024 | 139 | $79 | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q1 2026 | 255 | $61 | 0.00% | Reduce |
| BlackRock Inc history | Q2 2025 | 259 | $60 | 0.00% | Hold |
| Bank of America Corp history | Q4 2025 | 46 | $53 | 0.00% | Add |
| Renaissance Technologies history | Q4 2023 | 17.08K | $26 | 0.00% | New |
| PNC Financial Services history | Q2 2024 | 100 | $20 | 0.00% | Hold |
New Positions (Q2 2026)
- UBS Group AG 7.88K sh · $1.34K
Fully Exited (vs previous quarter)
- JPMorgan Chase & Co sold 1.04K sh · $248
- Fidelity Management & Research (FMR) sold 255 sh · $61
Fund Position History — shares by quarter (top 19 funds)
| Fund | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Geode Capital Management | — | — | — | — | — | — | — | — | 102.24K | 107.11K | — | 39.61K | 160.02K | 251.92K | 232.58K | 29.59K | 41.93K | 63.02K | 114.55K |
| Northern Trust Corp | — | — | — | — | — | — | — | — | — | — | — | — | 19.93K | 48.69K | 48.69K | — | 17.76K | 17.76K | 17.76K |
| Morgan Stanley | — | — | — | — | — | — | — | — | 19.19K | 19.19K | 19.19K | 2.02K | 2.52K | 2.02K | 1.92K | 387 | 1.47K | 9.47K | 13.24K |
| UBS Group AG | 7.42K | 1.55K | 1.59K | — | 24 | 11 | 10 | 10 | 10 | 10 | 10 | 922 | 8.80K | 1 | 44.90K | 2.56K | 7.51K | — | 7.88K |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1 | 14 | 4.59K |
| Fidelity Management & Research (FMR) | — | — | — | — | — | — | — | — | — | — | — | 141 | — | — | — | 125 | 22.01K | 255 | — |
| JPMorgan Chase & Co | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 63 | 9 | — | 1.04K | — |
| Bank of America Corp | — | — | — | — | — | — | — | 100 | — | — | 273 | 48 | 1.06K | 222 | 326 | 30 | 46 | — | — |
| Vanguard Group | — | — | — | — | — | — | — | — | 12.45K | 14.94K | 14.94K | — | 61.37K | 353.38K | 353.38K | 34.73K | 34.73K | — | — |
| Citadel Advisors | — | — | — | 93.84K | 93.85K | — | — | — | — | — | 125.91K | — | — | — | 71.20K | — | — | — | — |
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | 259 | 259 | 259 | 259 | — | — | — | — |
| Goldman Sachs Group | 89.97K | 127.08K | 126.35K | — | — | — | — | — | — | — | — | — | 17.51K | — | 13.21K | — | — | — | — |
| Deutsche Bank AG | 100.00K | 100.00K | 100.00K | — | — | 139.49K | 139.49K | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | — | — | — | — | — | — | — | — | 17.08K | — | — | — | — | — | — | — | — | — | — |
| D. E. Shaw & Co | 815.82K | 819.77K | 820.02K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Marshall Wace | 1.06M | 1.06M | 1.06M | — | — | — | — | — | — | 61.87K | 61.87K | — | — | — | — | — | — | — | — |
| Millennium Management | — | 494.80K | 1.05M | — | — | — | — | — | 102.32K | — | — | — | 136.14K | — | — | — | — | — | — |
| PNC Financial Services | — | — | — | — | — | — | — | 100 | 100 | 100 | 100 | — | — | — | — | — | — | — | — |
| Wells Fargo & Co | — | — | — | — | — | — | — | — | 138 | 139 | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details